Clinical trial
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal…
NCT00010140 · International Collaborative Cancer Group, Other · Unknown status
Key facts
| NCT number | NCT00010140 |
|---|---|
| Title | Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer |
| Official title | A Multicenter Randomized Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients |
| Lead sponsor | International Collaborative Cancer Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, epirubicin hydrochloride, tamoxifen citrate, adjuvant therapy |
| Start date | Aug 1, 1997 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: